Tolmar is a pharmaceutical company specializing in product development, manufacturing, and commercialization within the therapeutic areas of urology, oncology, and dermatology. Established with a focus on specialty markets, the company operates state-of-the-art manufacturing facilities and manages all aspects of the pharmaceutical lifecycle, from research and clinical development to regulatory approval and global distribution. A key product for the company is ELIGARD® (leuprolide acetate), used for the palliative treatment of advanced prostate cancer.

Founded in

France